Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $44.0000 (4.14%) ($42.0500 - $44.0000) on Thu. Mar. 8, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.49% (three month average) | RSI | 42 | Latest Price | $44.0000(4.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 3.3% a day on average for past five trading days. | Weekly Trend | ATRA declines -2.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(51%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -3.245% in a week (0% probabilities). VIXM(-15%) TLT(-14%) UUP(-11%) UNG(-5%) VXX(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.245% (StdDev 6.49%) | Hourly BBV | 0 () | Intraday Trend | 4.5% | | | |
|
5 Day Moving Average | $42.41(3.75%) | 10 Day Moving Average | $41.76(5.36%) | 20 Day Moving Average | $42.61(3.26%) | To recent high | -9% | To recent low | 203.4% | Market Cap | $3.27b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |